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Simple Summary: Obesity contributes to one-fifth of cancer deaths. Ovarian cancer (OC) progression
is frequently asymptomatic, making its early detection difficult and its chance of survival low.
OC expresses highly tumorigenic chemokines, CXCL1/8, of which the specific receptor CXCR2 is
increased in the adipocytes. So, the CXCL1/8-CXCR2 axis may appear as a molecular link between
obesity and OC. Here, we generated adipocyte-specific CXCR2 conditional knockout (cKO) mice to
investigate how this CXCR2 cKO affects the peritoneal dissemination of OC under obese conditions.
High-fat, diet-induced obese mice had a shorter survival than lean mice. Particularly, obese cKO
mice had a reduced tumor burden but increased ascites accumulation, showing a decreased floating
tumor burden in ascites, as well as proliferation and macrophage infiltration in tumors compared to
obese wild-type mice. Despite the ascites accumulation, adipocyte-specific CXCR2 cKO reduced the
obesity-induced tumor burden, likely altering the peritoneal tumor microenvironment of OC.
Abstract: Obesity contributes to ovarian cancer (OC) progression via tumorigenic chemokines.
Adipocytes and OC cells highly express CXCR2, and its ligands CXCL1/8, respectively, indicating
that the CXCL1/8-CXCR2 axis is a molecular link between obesity and OC. Here, we investigated
how the adipocyte-specific CXCR2 conditional knockout (cKO) affected the peritoneal tumor microenvironment of OC in a high-fat diet (HFD)-induced obese mouse model. We first generated
adipocyte-specific CXCR2 cKO in mice: adipose tissues were not different in crown-like structures
and adipocyte size between the wild-type (WT) and cKO mice but expressed lower levels of CCL2/6
compared to the obese WT mice. HFD-induced obese mice had a shorter survival time than lean mice.
Particularly, obese WT and cKO mice developed higher tumors and ascites burdens, respectively. The
ascites from the obese cKO mice showed increased vacuole clumps but decreased the floating tumor
burden, tumor-attached macrophages, triglyceride, free fatty acid, CCL2, and TNF levels compared
to obese WT mice. A tumor analysis revealed that obese cKO mice attenuated inflammatory areas,
PCNA, and F4/80 compared to obese WT mice, indicating a reduced tumor burden, and there were
positive relationships between the ascites and tumor parameters. Taken together, the adipocytespecific CXCR2 cKO was associated with obesity-induced ascites despite a reduced tumor burden,
likely altering the peritoneal tumor microenvironment of OC.
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1. Introduction
Obesity, a disease defined by excessive fat accumulation which impairs health, is an
escalating global epidemic: according to the World Health Organization, there are predicted
to be 1.12 billion obese adults by 2030 [1]. Obesity is a known risk factor for many diseases,
such as diabetes, cardiovascular disease, and cancer [2]. Several types of cancers are related
to obesity, including cancers of the pancreas, corpus uteri (endometrium), esophagus,
rectum, kidney, liver, colon, gallbladder, breast, thyroid, and ovary [3]. Obesity contributes
to one-fifth of cancer deaths, with abnormal metabolism, chronic inflammation, growth
factor signaling, and angiogenesis being the primary drivers of obesity-related cancers [4,5].
The direct molecular factors linking obesity and cancer are not fully understood, but the
organ-dependent crosstalk between the adipose tissue and carcinomas via the vascular
endothelial growth factor (VEGF), interleukin 6 (IL-6), tumor necrosis factor α (TNFα), and
other mechanisms are implicated [6].
Among obesity-related cancers, ovarian cancer (OC) is the second leading cause of
gynecological cancer-related death in women worldwide [7]. The asymptomatic and rapid
progression of OC makes its early detection difficult, resulting in a low 5-year survival rate
of only 49.1% [8]. This low survival rate is also attributable to the frequent and aggressive
metastasis of OC throughout the peritoneal cavity, forming the secondary tumor foci and
ascites [9]. The accumulation of malignant ascites provides growth factors, fatty acids,
and chemokines to the OC cells, leading to a more aggressive and metastatic OC and
a poor prognosis [10,11]. Chemokines are recognized as critical mediators in the tumor
microenvironment and play a central role in regulating the inflammatory response, contributing to the progression and metastasis of OC [12]. Specifically, chemokines, such as
CCL20, CXCL1–3, CXCL5, and CXCL8, are highly expressed in OC cells and the tumor
microenvironment of OC [13–15]. These proangiogenic and tumorigenic chemokines are
closely associated with the CXC chemokine receptor type 2 (CXCR2) [16–19]. CXCR2 is
highly expressed in tumors of some OC patients and may promote OC progression [15,17].
In addition, CXCR2-mediated signaling is involved in the tumorigenicity of OC [18,19].
Interestingly, mouse adipocytes expressed higher levels of CXCR2 mRNA compared to
preadipocytes [20] and OC progression could be accelerated by an obesity-induced inflammatory burden [21]. Based on the high expression levels of CXCL1–3 and CXCL8 in
OC cells [13,14] and the high levels of CXCR2 in adipocytes [20], the CXCL1/8-CXCR2
axis is proposed as a molecular link between obesity and OC. CXCR2 transfected OC
cells expressed higher levels of CXCL1/2 compared to CXCR2 null OC cells [19] and
obesity-induced, higher circulating CXCL1 levels [21], indicating a positive feedback loop.
CXCR2 knockout (KO) mice had a significantly reduced tumor burden in other cancers,
such as murine lung, prostate, and renal cancer models, compared to CXCR2 wild-type
(WT) mice [22–24]. These findings indicate that CXCR2 may be a critical molecular target
to attenuate the progression of OC. However, the global deletion of CXCR2 using KO mice
is not suitable for a diet-induced obesity model due to fewer and smaller adipocytes in
this KO mouse model [25]. Accordingly, we generated adipocyte-specific, CXCR2 conditional knockout (cKO) mice for the first time to minimize the undesirable effects of CXCR2
deletion in other tissues, including immune cells. These CXCR2 cKO mice were employed
to clarify the roles of adipocyte-derived CXCR2 signaling in the peritoneal dissemination
of OC.
In this study, we investigated if adipocyte-specific CXCR2 cKO could modulate the
peritoneal dissemination of OC in a pseudo-postmenopausal, diet-induced obese mouse
model. We assessed the peritoneal tumor burden of OC under lean and obese states by
feeding a normal diet (ND) and a high-fat diet (HFD), respectively, in adipocyte-specific
CXCR2 cKO and WT mice.
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2. Materials and Methods
2. Materials and Methods
2.1. Generation of Adipocyte-Specific CXCR2 cKO Mice
2.1. Generation of Adipocyte-Specific CXCR2 cKO Mice
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on SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes according to established procedures [19]. IL-8RB (K-19) antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) was used to detect CXCR2 protein levels. β-actin (C4) antibody
(Santa Cruz Biotechnology) served as an internal loading control. The targeted protein
bands were visualized by chemiluminescence detection kits (MilliporeSigma, St. Louis,
MO, USA).
2.3. Histological Analysis of Adipose Tissues
Perigonadal adipose samples from CXCR2 WT and cKO mice fed with ND and HFD
without tumors were fixed in neutral buffered formalin for 7 days and then processed for
paraffin embedding. Samples were sectioned at 5 µm and then processed for hematoxylin
and eosin (H&E) staining. Digital images of slides were captured with BZ-X700 All-in-One
Fluorescence Microscope (KEYENCE, Itasca, IL, USA). Adipocyte size was calculated as the
mean area of 100 random adipocytes in digital images with ImageJ. Crown-like structures
were counted from 10 random fields in microscopic images with 10× power fields.
2.4. Proteomic Array for Chemokine Signature
Chemokine signatures in adipose tissues and ascites were evaluated using Proteome
Profiler Mouse Chemokine Array (ARY020; R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions as described previously [21]. Spot intensity of spots
was calculated with ImageJ by subtracting average background signals and normalizing
with reference spots.
2.5. Mouse Peritoneal Dissemination of OC in a Postmenopausal Obese Mouse Model
Mouse peritoneal dissemination of OC and diet-induced obesity at a pseudopostmenopausal state were performed under guidelines approved by the Institutional
Animal Care and Use Committee at Meharry Medical College (eProtocol#16-06-566) and
the National Institutes of Health (NIH) guide for the Care and Use of Laboratory Animals.
Six- to eight-week-old CXCR2 WT and cKO mice were ovariectomized (OVX) to create
a pseudo-postmenopausal state. The mice were maintained in a specific pathogen-free
animal housing facility at 22 ◦ C ± 2 ◦ C and 40–60% humidity under a 12:12 light: dark
cycle. The mice were maintained on ND (5% kcal from fat) and HFD (D12492; 60% kcal
from fat) obtained from Research Diets Inc. (New Brunswick, NJ, USA) for 16 weeks to
produce lean and obese mice, respectively. We grouped mice as follows: (1) ND-WT; (2)
HFD-WT; (3) ND-cKO; and (4) HFD-cKO. After confirming body weight gain in obese
mice, mouse ID8 OC cells (3 × 106 cells/mouse in a volume of 0.2 mL PBS) were injected
intraperitoneally into all mice. Along with weekly body weight, mice were monitored 3
times per week to assess animal health such as hunched posture, lethargy and inactivity,
impaired ambulation, shallow or labored breathing, hair coat condition, and change in the
body weight. Mice showing signs of increase in body weight due to tumors and changes in
appearance and activity were observed daily. When an increase of 20% in body weight,
extensive ascites accumulation, or sluggish activity were observed, animals were euthanized for humane reasons. Tumors in the diaphragm, omentum, and pelvic sites were
investigated for spreading index and omental tumor tissues were served for histological
examination using H&E staining and immunohistochemistry with targeted antibodies. The
survival times of the mice were compared between each group.
2.6. Cellular Characteristics in OC-Induced Ascites
Ascites collected via intraperitoneal aspiration were immediately smeared on slides
and the slides were fixed in methanol and stained with Wright’s Giemsa stain. Ascitic
fluid was prepared by centrifuging at 1500 rpm for 5 min and stored in a −80 ◦ C freezer
for further analysis. Digital images of slides were captured with BZ-X700 All-in-One
Fluorescence Microscope (KEYENCE, Itasca, IL, USA). Floating cells in OC-induced ascites
were quantitatively analyzed by calculating from 5 random fields of each slide using ImageJ
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for area measurement. Numbers of monocytes (Mo) and macrophages (Mϕ) in OC-induced
ascites were obtained from 5 random fields of each slide under microscope. Comparisons
of vacuole and non-vacuole clumps showing cytoplasmic lipid droplets were obtained
from 10 random fields of each slide under microscope.
2.7. Biochemical Analyses in OC-Induced Ascites
Triglyceride and free fatty acid levels in ascites were measured by EnzyChrom™
Triglyceride (ETGA-200) and Free Fatty Acid (EFFA-100) Assay Kits (BioAssay Systems,
Hayward, CA, USA) according to the manufacturer’s instructions. The optical density of
each well was determined using a microplate reader at 570 nm wavelength. Total protein
levels for ascites were measured using the Bio-Rad protein assay based on the Bradford
dye-binding method (Bio-Rad). Glucose levels in ascites were measured by Glucose
Colorimetric Assay Kit (Cayman Chemical, Ann Arbor, MI, USA). The absorbance of each
well was determined using a microplate reader at 514 nm wavelength. Vascular endothelial
growth factor (VEGF) levels in ascites were measured by Mouse VEGF Quantikine ELISA
Kit (MMV00; R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s
instructions. The optical density of each well was determined using a microplate reader set
to 450 nm with wavelength correction of 570 nm. Tumor necrosis factor-α (TNFα) levels
in ascites were measured by Mouse TNFα enzyme-linked immunosorbent assay (ELISA)
kit (RAB0477; MilliporeSigma) according to the manufacturer’s instructions. The optical
density of each well was determined using a microplate reader at 450 nm wavelength.
2.8. Histological and Immunohistochemical Evaluation of Tumor Tissues
Omental tumor samples were analyzed using H&E stain and immunohistochemistry.
Paraffin slide sections were washed three times in xylenes followed by rehydration in a series of two alcohol washes (100% and 95%). Sections were treated for heat antigen retrieval
in EDTA solution (1 mM, pH 8.0). After blocked in goat serum, sections were incubated
overnight with specific primary antibodies as follows: PCNA (PC10) for proliferating cells,
F4/80 (D2S9R) for Mϕ, Arginase-1 (D4E3M) for MDSCs, CD4 (D7D2Z) for CD4 T cells, and
CD8α (D4W2Z) for CD8 T cells (Cell Signaling Tech., Danvers, MA, USA). Sections were
incubated with secondary antibody matched with primary antibody and developed using
SignalStain® DAB Substrate kit (#8059; Cell Signaling Tech.) with hematoxylin counterstain.
Digital images of slides were captured with BZ-X700 All-in-One Fluorescence Microscope
(KEYENCE). Quantitative analysis of inflammatory area in H&E stain was calculated using
ImageJ with selection of inflammatory area through color threshold followed by particles
analysis. Quantitative analysis of PCNA and immune cell dispositions was performed
using ImageJ with brown color selection through color deconvolution of hematoxylin and
3,30 -diaminobenzidine (DAB) staining followed by intensity analysis. Quantitative analysis
was obtained from 3–5 random fields of each slide (10×).
2.9. Statistical Analysis
Data values were expressed as the mean ± the standard error of the mean (SEM). Data
were analyzed and compared using unpaired Student’s t-tests and one-way ANOVA as
appropriate. If statistical significance (p ≤ 0.05) was determined by ANOVA, the data were
further analyzed by Tukey’s pairwise comparison to detect specific differences between
treatment groups. R-squared values for correlations between continuous variables were
calculated from linear regression from the Data Analysis Tools in MS-Excel. Differences in
survival plots were evaluated with the log-rank test [26].
3. Results
3.1. Adipocyte-Specific CXCR2 cKO Mice Have Low Levels of CCL2/6 in Adipose Tissues
Compared to Those in CXCR2 WT Mice
CXCR2-mediated signaling was involved in the tumorigenicity of OC [18,19] and
adipogenesis [20]. An adipocyte-driven chemokine network appeared to involve CXCR2-
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mediated signaling [20,25,27], launching a tumorigenic burden of OC cells which expressed
high levels of CXCL1–3 and CXCL8 [13,14]. Accordingly, targeting CXCR2 may be critical in blocking the obesity-induced progression of OC. CXCR2 KO mice (C129S2(B6)Cxcr2tm1Mwm /J mice, Jackson Laboratory) were not susceptible to diet-induced obesity,
showing a lower weight gain. Thus, we first generated adipocyte-specific CXCR2 cKO mice
by crossing C57BL/6-Cxcr2tm1Rmra /J (JAX #024638) with B6.FVB-Tg (Adipoq-cre)1Evdr/J
(JAX #028020) (Figure 1A). All mice were ovariectomized to avoid the suppressive effects of
estrogen on obesity [28,29] and to create a pseudo-postmenopausal state, as most ovarian
cancers develop after menopause. Before the intraperitoneal injection of ID8 OC cells, we
confirmed the predominant expression levels of the CXCR2 protein in the adipose tissues
from ND- and HFD-fed WT mice, but little expression of CXCR2 in ND- and HFD-fed
cKO mice (Figures 1B and S1). The adipose tissues in HFD-fed WT mice showed a larger
increase in CXCR2 protein levels compared to ND-fed mice (Figure 1B), indicating an
obesity-induced CXCR2 expression. The adipocyte size showed an approximate 2-fold
increase in HFD-fed mice compared to ND-fed mice but there was no significant difference
between CXCR2 WT and cKO mice (Figure 1C). Crown-like structures in the adipose
tissues were not different between CXCR2 WT and cKO mice but there was an approximate 2-fold increase in both HFD-fed mice (Figure 1D), indicating the stimulation of the
proinflammatory processes in the adipose tissue due to obesity in HFD-fed mice. The
chemokine signatures in adipose tissues revealed the induction of high levels of CCL2 and
CCL6 proteins in HFD-fed WT mice, but not in HFD-fed cKO mice (Figures 1E and S2).
Interestingly, ND-fed WT and cKO mice showed low levels of chemerin and high levels
of IL-16 in the adipose tissues, respectively (Figure 1E). HFD-fed mice had low levels of
adipsin compared to ND-fed mice (Figure 1E). A decreased adipsin activity was observed
as a common feature of several experimental models of obesity [30], validating the burden
of obesity induced by HFD.
3.2. Obese CXCR2 WT Mice Have Greater Tumor Burdens, While Obese CXCR2 cKO Mice Have
Greater Ascites Burdens
There were no significant differences in body weight between WT and cKO mice at
the start of our experiments and in the body weight gain after ND and HFD conditions
(Figure 2A). The HFD-fed obese mice had approximately 2-fold higher body weights
compared to ND-fed lean mice. Although lean CXCR2 cKO mice had a decreasing trend
in body weight with an advanced tumor burden (from 9 weeks after OC cell injection),
this was not significant (Figure 2A). HFD-fed obese mice had a shorter survival than
ND-fed mice, regardless of the CXCR2 cKO in the adipose tissues, with outcomes of
117 ± 3.1 days in ND-WT, 102 ± 3.4 days in HFD-WT, 113 ± 4.5 days in ND-cKO, and
105 ± 2.9 days in HFD-cKO mice (Figure 2B). Although our results supported a shorter
survival in OC patients with obesity [31,32], adipocyte-specific CXCR2 cKO was not likely
to critically affect the survival of OC. The peritoneal dissemination of ID8 OC cells was
observed in all mice, spreading widely into the parietal and visceral peritoneum with a
solid tumor formation on the omentum (Figure 2C). The obese WT mice had increased
tumor weights compared to the lean mice, while obese cKO mice tended to have higher
tumor weights without statistical significance (Figure 2D). The spleen weights shared a
similar pattern (Figure 2E). Interestingly, obese cKO mice had a greater accumulation of
ascites in the peritoneal cavity compared to other groups (Figure 2F). This indicated that
adipocyte-specific CXCR2 cKO was related to the obesity-induced accumulation of ascites
in OC.
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burden and tumor spread in the parietal and visceral peritoneum, respectively. Representative pictures were obtained from
pictures were obtained from each group. Comparison of (D) tumor weight, (E) spleen weight, and (F) ascites volumes in
each group.
of (D)
weight,
spleenND-cKO
weight, and
ascites
volumes
ND-WT
for ascites
and
ND-WT
(n = Comparison
8 for ascites and
14tumor
for tumor
and(E)
spleen),
(n = (F)
6 for
ascites,
10 for in
tumor,
and(n
9=
for8 spleen),
HFD14
for
tumor
and
spleen),
ND-cKO
(n
=
6
for
ascites,
10
for
tumor,
and
9
for
spleen),
HFD-WT
(n
=
8
for
ascites
and
11
for
WT (n = 8 for ascites and 11 for tumor and spleen), and HFD-cKO (n = 7 for all parameters) mice. * indicates a significant
tumor and(pspleen),
and HFD-cKO
7 for all parameters)
* indicates
a significant
difference
difference
≤ 0.05) between
groups(nas=analyzed
by ANOVA mice.
and Tukey’s
pairwise
comparison
tests. (p ≤ 0.05) between
groups as analyzed by ANOVA and Tukey’s pairwise comparison tests.

3.3. Adipocyte-Specific CXCR2 cKO Mice Have Lower Floating Tumor Burdens and Tumor3.3. Adipocyte-Specific
CXCR2 cKO
Have Vacuole
Lower Floating
Burdens and
Attached
Monocytes/Macrophages
butMice
Increased
ClumpsTumor
in OC-Induced
Ascites after
Tumor-Attached
Monocytes/Macrophages but Increased Vacuole Clumps in OC-Induced Ascites
Diet-Induced
Obesity
after Diet-Induced Obesity
Because obese CXCR2 cKO mice had greater ascites burdens (Figure 2F), we perBecause obese CXCR2 cKO mice had greater ascites burdens (Figure 2F), we performed
formed ascitic analysis using ascites smeared with Wright’s Giemsa stain. The floating
ascitic analysis using ascites smeared with Wright’s Giemsa stain. The floating cells in the
cells in the OC-induced ascites were categorized from large to small areas in the following
OC-induced ascites were categorized from large to small areas in the following order: HFDorder:
ND-WT >mice
ND-cKO
mice
(Figure
3A). We the
observed
the morWT > HFD-WT
HFD-cKO>>HFD-cKO
ND-WT >> ND-cKO
(Figure
3A).
We observed
morphological
phological
patterns
of
floating
tumor
cells
in
OC-induced
ascites
as
follows:
intact
floating
patterns of floating tumor cells in OC-induced ascites as follows: intact floating tumor
cells,
tumor
cells,
Moand
Mφ-attached
floating
tumor
cells,
dispersed
floating
tumor
cells
with
Mo- and Mϕ-attached floating tumor cells, dispersed floating tumor cells with immune
immune
cells,
andclumps
small clumps
of floating
cells attached
Mo/Mφ
(Figure
3B1–
cells, and
small
of floating
tumortumor
cells attached
with with
Mo/Mϕ
(Figure
3(B1–4)).
4).
Supposedly,
the
tumor
cells
floating
without
the
attached
immune
cells
seemed
to
Supposedly, the tumor cells floating without the attached immune cells seemed to be
be
detached
detachedfrom
from the
the original
original tumor
tumor sites
sites just
just before
before the
the immune
immune cells
cells attached
attached to
to the
the tumor
tumor
clumps
cells,
clumps (Figure
(Figure 3B1).
3(B1)).Immune
Immune
cells,such
suchasasMo
Moand
andMφ
Mϕseemed
seemedto
toapproach
approach to
to tumor
tumor

Cancers 2021, 13, 5033
Cancers 2021, 13, x

8 of 18
8 of 17

clumps in order to attack (Figure 3(B2)). Mo and Mϕ attached to the tumor cells which
seemed
seemedtotodisperse
dispersetumor
tumorclumps,
clumps,impeding
impedingthe
thetight
tightattachment
attachmentbetween
betweentumor
tumorcells
cells
(Figure
3B3).
Finally,
the
dispersed
small
tumor
clumps
seemed
to
be
further
attacked
(Figure 3(B3)). Finally, the dispersed small tumor clumps seemed to be further attackedby
by
immune
immunecells,
cells,such
suchas
asMo
Mo and
and Mφ
Mϕ (Figure
(Figure 3B4).
3(B4)).We
Wealso
alsoobserved
observedsome
somemorphological
morphological
patterns
patternsbetween
betweenimmune
immuneand
andtumor
tumorcells
cellsininOC-induced
OC-inducedascites.
ascites.Few
Fewlymphocytes
lymphocytesand
and
Mo
were
floating
in
the
ascites
(Figure
3C).
Signet,
ring-like
cells
containing
cytoplasmic
Mo were floating in the ascites (Figure 3C). Signet, ring-like cells containing cytoplasmic
vacuoles
vacuoleswere
wereobserved
observedininHFD-fed
HFD-fedmice
micebut
butwere
wererare
rareininND-fed
ND-fedmice
mice(Figure
(Figure3C).
3C).The
The
distribution
of
Mo
and
Mφ
in
OC-induced
ascites
descended
in
the
following
order:
distribution of Mo and Mϕ in OC-induced ascites descended in the following order:HFDHFDWT
WT>>HFD-cKO
HFD-cKO>>ND-WT
ND-WT> >ND-cKO
ND-cKOmice
mice(Figure
(Figure3D),
3D),being
beingconsistent
consistentwith
withthe
thefloating
floating
tumor
cells
(Figure
3A).
Almost
all
Mo
and
Mφ
in
the
OC-induced
ascites
were
tumor cells (Figure 3A). Almost all Mo and Mϕ in the OC-induced ascites wereattached
attached
tototumor
tumorclumps
clumpsbut
butsmall
smallnumbers
numbersofofthem
themwere
werefloating
floatingininthe
theascites.
ascites.Vacuole
Vacuoleclumps
clumps
showing
the OC-induced
OC-inducedascites
asciteswere
werefrequently
frequentlyobserved
observedin
showingcytoplasmic
cytoplasmiclipid
lipid droplets
droplets in
in the
inHFD-fed
HFD-fed
mice
very
rarely
in ND-fed
mice,
demonstrating
higher
in
mice
butbut
very
rarely
in ND-fed
mice,
demonstrating
theirtheir
higher
levelslevels
in obese
obese
CXCR2
cKO
mice
(Figure
3E).
CXCR2 cKO mice (Figure 3E).

Figure3.3.Cellular
Cellularcharacteristics
characteristicsofofOC-induced
OC-inducedascites
ascitesininaapostmenopausal,
postmenopausal,diet-induced,
diet-induced,obese
obesemouse
mousemodel
modelbetween
between
Figure
CXCR2
WT
and
cKO
mice.
(A)
Comparison
of
floating
cells
in
OC-induced
ascites
obtained
from
lean
and
obese
CXCR2 WT and cKO mice. (A) Comparison of floating cells in OC-induced ascites obtained from lean and obeseCXCR2
CXCR2
WT
bearing
mouse
ID8
OCOC
cells.
Area
measurement
was was
calculated
fromfrom
5 random
fieldsfields
of each
WTand
andcKO
cKOmice
mice
bearing
mouse
ID8
cells.
Area
measurement
calculated
5 random
ofslide
eachwith
slide
ImageJ.
(B) Morphological
patterns
of floating
tumor
cellscells
in OC-induced
ascites.
B1:B1:
intact
floating
tumor
with ImageJ.
(B) Morphological
patterns
of floating
tumor
in OC-induced
ascites.
intact
floating
tumorcells;
cells;B2:
B2:
Mo/Mφ-attached
floating
Mo/Mϕ-attached
floatingtumor
tumorcells;
cells;B3:
B3:dispersed
dispersedfloating
floatingtumor
tumorcells
cellswith
withimmune
immunecells;
cells;B4:
B4:small
smallclumps
clumpsofoffloating
floating
tumor cells attached with monocyte/Mφ. Yellow arrows indicate Mo/Mφ. (C) Morphological patterns between immune
tumor cells attached with monocyte/Mϕ. Yellow arrows indicate Mo/Mϕ. (C) Morphological patterns between immune
and tumor cells in OC-induced ascites. Lym: lymphocytes. Red asterisks: signet ring-like cells containing cytoplasmic
and tumor cells in OC-induced ascites. Lym: lymphocytes. Red asterisks: signet ring-like cells containing cytoplasmic
vacuoles. (D) Numerical comparison of Mo and Mφ in OC-induced ascites from ND-WT, ND-cKO, HFD-WT, and HFDvacuoles.
Numerical
of Mo and
OC-induced
ascites
from
ND-WT,
ND-cKO,
HFD-WT,
HFD-cKO
cKO mice. (D)
Yellow
arrowscomparison
indicate attached
Mo Mϕ
andinMφ.
Cell number
was
obtained
from
5 random
fields and
of each
slide
mice.
Yellow
arrows
indicate
attached
Mo
and
Mϕ.
Cell
number
was
obtained
from
5
random
fields
of
each
slide
under microscope. (E) Comparison of vacuole and non-vacuole clumps in OC-induced ascites; clump number wasunder
obmicroscope.
(E)random
Comparison
andunder
non-vacuole
clumps
in OC-induced
ascites;
clump number
was
obtained from
tained
from 10
fields of
of vacuole
each slide
microscope.
Yellow
arrows indicate
vacuoles.
*, **, and
# indicates
significant
difference
≤ 0.05)
between
groups as analyzed
by ANOVA
and
Tukey’s*,pairwise
tests. difference
10 random
fields of(peach
slide
under microscope.
Yellow arrows
indicate
vacuoles.
**, and #comparison
indicates significant
(p ≤ 0.05) between groups as analyzed by ANOVA and Tukey’s pairwise comparison tests.

3.4. Ascites in Obese CXCR2 cKO Mice Showed Lower Levels of Triglycerides, Free Fatty Acids,
3.4. Ascites
in Obese
CXCR2
cKO Mice
Showed
CCL2,
and TNF
Compared
to Those
in Obese
WT Lower
Mice Levels of Triglycerides, Free Fatty Acids,
CCL2, and TNF Compared to Those in Obese WT Mice
The ascites from HFD-fed CXCR2 WT mice had high levels of triglycerides and free
The ascites
HFD-fed
CXCR2
WT mice
hadthe
high
levelscKO
of triglycerides
andhigh
free
fatty acids
(Figurefrom
4A,B).
Although
the ascites
from
ND-fed
mice showed
fatty
acids
(Figure
4A,B).
Although
the
ascites
from
the
ND-fed
cKO
mice
showed
high
levels of triglycerides and free fatty acids compared to those from ND-fed WT mice, HFD
levels
of triglycerides
and increase
free fattythese
acidslevels
compared
those from ND-fed
WT
mice, cKO
HFD
was
unable
to significantly
in thetoOC-induced
ascites of
CXCR2
was
unable
to
significantly
increase
these
levels
in
the
OC-induced
ascites
of
CXCR2
mice (Figure 4A,B). Consequently, we evaluated if adipocyte-specific CXCR2 cKO influcKO mice
(Figure 4A,B).
Consequently,
we evaluated
if adipocyte-specific
CXCR2
cKO
enced
the chemokine
signatures
in OC-induced
ascites using
proteomic arrays.
Although
OC-induced ascites contained high levels of CCL6, CCL8, CCL9/10, CXCL12, and
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influenced the chemokine signatures in OC-induced ascites using proteomic arrays. Although OC-induced ascites contained high levels of CCL6, CCL8, CCL9/10, CXCL12, and
CXCL16,
CXCL16, these
thesechemokines
chemokines showed
showed no
nosignificant
significant difference
difference between
between obese
obese and
and lean
lean mice
mice
or
between
WT
and
cKO
mice
(Figure
4C,D).
Interestingly,
CCL2
protein
levels
were
sigor between WT and cKO mice (Figures 4C,D and S3). Interestingly, CCL2 protein levels
nificantly
higher inhigher
obese in
WT
miceWT
compared
to those to
in those
all theinother
groups
were significantly
obese
mice compared
all the
other (Figure
groups
4C,D).
Although
obese
WT
mice
tended
to
show
higher
protein
levels
of
CXCL1,
CXCL2,
(Figure 4C,D). Although obese WT mice tended to show higher protein levels of CXCL1,
CXCL5,
CXCL10
(Figure 4D),
there4D),
were
no were
statistical
differences
between between
groups.
CXCL2, and
CXCL5,
and CXCL10
(Figure
there
no statistical
differences
The
total
protein
amount
in
ascites
was
similar
between
groups
(Figure
4E),
indicating
groups. The total protein amount in ascites was similar between groups (Figure 4E), indithat
thethat
reduced
levels oflevels
CCL2ofinCCL2
the ascites
obeseofcKO
mice
were
duenot
to differcating
the reduced
in the of
ascites
obese
cKO
micenot
were
due to
ences
in volume
or dilution.
The levels
of glucose
and VEGF
in OC-induced
ascites
had
differences
in volume
or dilution.
The levels
of glucose
and VEGF
in OC-induced
ascites
no
differences
between
the the
groups
(Figure
4F,G),
hadsignificant
no significant
differences
between
groups
(Figure
4F,G),while
whileobese
obesecKO
cKO mice
mice
showed
showed lower
lower levels
levels of
of secreted
secreted TNFα
TNFα compared
compared to
to those
those in
in obese
obese WT
WT mice
mice (Figure
(Figure 4H).

Figure 4. Biochemical
in in
a postmenopausal
diet-induced
obese
mouse
model
between
Figure
Biochemical characteristics
characteristicsofofOC-induced
OC-inducedascites
ascites
a postmenopausal
diet-induced
obese
mouse
model
between
CXCR2
WT
and
cKO
mice.
(A)
Triglyceride
and
(B)
free
fatty
acid
levels
in
OC-induced
ascites
of
ND-WT
(n
=
8),
CXCR2 WT and cKO mice. (A) Triglyceride and (B) free fatty acid levels in OC-induced ascites of ND-WT (n = 8), ND-cKO
ND-cKO
(n
=
6),
HFD-WT
(n
=
8),
and
HFD-cKO
(n
=
7)
mice
using
quantitative
colorimetric
assays
with
duplicate
meas(n = 6), HFD-WT (n = 8), and HFD-cKO (n = 7) mice using quantitative colorimetric assays with duplicate measurements.
urements.
(C) Chemokine
signatures
ascitesND-cKO,
of ND-WT,
ND-cKO,
HFD-cKO
micearray.
by proteomic
array.
(C) Chemokine
signatures in
ascites of in
ND-WT,
HFD-WT,
andHFD-WT,
HFD-cKOand
mice
by proteomic
(D) Intensity
of
(D)
Intensity
of
chemokine
expression
profiles
in
OC-induced
ascites
of
ND-WT,
ND-cKO,
HFD-WT,
and
HFD-cKO
mice.
chemokine expression profiles in OC-induced ascites of ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. (E) Total protein,
(E) Total protein, (F) glucose, (G) VEGF, and (H) TNF levels in OC-induced ascites of ND-WT, ND-cKO, HFD-WT, and
(F) glucose, (G) VEGF, and (H) TNF levels in OC-induced ascites of ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. * and
HFD-cKO mice. * and # indicates significant increases and decreases (p ≤ 0.05), respectively, between groups as analyzed
# indicates
increases
andcomparison
decreases (ptests.
≤ 0.05), respectively, between groups as analyzed by ANOVA and Tukey’s
by
ANOVAsignificant
and Tukey’s
pairwise
pairwise comparison tests.

3.5. Obese CXCR2 cKO Mice Show Attenuated Inflammatory Area, PCNA, and F4/80 in Tumor
3.5. Obese CXCR2 cKO Mice Show Attenuated Inflammatory Area, PCNA, and F4/80 in Tumor
Tissues
Tissues Compared
Compared to
to Obese
Obese WT
WT Mice
Mice
We
tumor
tissues
as as
a frequent
sitesite
of
We evaluated
evaluatedthe
thehistological
histologicalfeatures
featuresofofomental
omental
tumor
tissues
a frequent
OC
in
the
peritoneal
cavity.
Both
obese
CXCR2
WT
and
cKO
mice
had
larger
and
more
of OC in the peritoneal cavity. Both obese CXCR2 WT and cKO mice had larger and
abundant
adipocytes
in the omental
tumor tissues
to thoseto
inthose
lean mice
(Figure
more abundant
adipocytes
in the omental
tumor compared
tissues compared
in lean
mice
5A).
Particularly,
the regions
adiposethe
and
tumor and
tissues
showed
evidence
of
(Figure
5A). Particularly,
thebetween
regionsthe
between
adipose
tumor
tissues
showed
an
inflammatory
reaction
as
shown
by
the
recruited
immune
cells;
this
was
greater
in
evidence of an inflammatory reaction as shown by the recruited immune cells; this was
HFD-fed WT mice compared to other groups (Figure 5A). Because proliferating the cell
nuclear antigen (PCNA) was a universal marker of proliferating cells, we evaluated PCNA
positive cells in omental tumor tissues. Most PCNA positive cells appeared at the edges
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greater in HFD-fed WT mice compared to other groups (Figure 5A). Because proliferating
10 of 17
the cell nuclear antigen (PCNA) was a universal marker of proliferating cells, we evaluated
PCNA positive cells in omental tumor tissues. Most PCNA positive cells appeared at
the edges of tumor tissues to rapidly develop tumor growth and regions between the
of
tumorand
tissues
to rapidly
develop5B).
tumor
growth and analysis
regions between
the adipose
and
adipose
tumor
tissues (Figure
A quantitative
of the PCNA
disposition
tumor
tissues
(Figure
5B).
A
quantitative
analysis
of
the
PCNA
disposition
revealed
that
revealed that HFD-fed WT mice had greater PCNA-positive cells compared to other groups
HFD-fed
WT mice had greater PCNA-positive cells compared to other groups (Figure 5B).
(Figure 5B).

Figure
5. Histological
in aa postmenopausal
postmenopausal diet-induced
diet-induced obese
obese mouse
mouse model
model
Figure 5.
Histological evaluation
evaluation of
of the
the omental
omental tumor
tumor tissues
tissues in
between CXCR2 WT and cKO mice. (A) Histological features of omental tumors in ND-WT, ND-cKO, HFD-WT, and HFDbetween CXCR2 WT and cKO mice. (A) Histological features of omental tumors in ND-WT, ND-cKO, HFD-WT, and HFDcKO mice using H&E stain. tm: tumor tissue, ft: fat tissue, if: inflammatory region. Quantitative analysis of inflammatory
cKO mice using H&E stain. tm: tumor tissue, ft: fat tissue, if: inflammatory region. Quantitative analysis of inflammatory
area was performed using ImageJ with selection of inflammatory area through color threshold followed by particles analarea was
performed using
ImageJ
with selection
inflammatory
through
color
threshold
followed and
by particles
analysis.
ysis.
(B) Disposition
of PCNA
positive
cells inof
omental
tumorsarea
from
ND-WT,
ND-cKO,
HFD-WT,
HFD-cKO
mice
(B)
Disposition
of
PCNA
positive
cells
in
omental
tumors
from
ND-WT,
ND-cKO,
HFD-WT,
and
HFD-cKO
mice
using immunohistochemistry. Quantitative analysis of PCNA disposition was performed using ImageJ with brownusing
color
immunohistochemistry.
Quantitative analysis
of PCNAand
disposition
was performed
using
ImageJanalysis.
with brown
color selection
selection
through color deconvolution
of hematoxylin
DAB staining
followed by
intensity
Quantitative
analysis
was color
obtained
from 3–5 random
fields of each
slide staining
(10×). * indicates
significant
(p ≤ 0.05) between
groups
through
deconvolution
of hematoxylin
and DAB
followedaby
intensitydifference
analysis. Quantitative
analysis
was
as
analyzed
by 3–5
ANOVA
andfields
Tukey’s
pairwise
tests. a significant difference (p ≤ 0.05) between groups as
obtained
from
random
of each
slidecomparison
(10×). * indicates
analyzed by ANOVA and Tukey’s pairwise comparison tests.

Because tumor infiltrating immune cells were associated with clinical outcomes, we
Because
infiltrating
immuneincells
were associated
withF4/80,
clinicalasoutcomes,
we
evaluated
thetumor
immune
cell infiltration
omental
tumor tissues.
a major Mφ
evaluated
the immune
cell infiltration
omental
tissues.
major Mϕ
marker,
appeared
intensively
in regionsin
between
thetumor
fat and
tumor F4/80,
tissues.as
A aquantitative
marker, appeared
intensively revealed
in regionsthat
between
the fat
tumor
quantitative
analysis
of F4/80 disposition
HFD-fed
WTand
mice
had tissues.
greater A
F4/80-positive
analysis
of F4/80
revealed(Figure
that HFD-fed
WT
mice had greatersuppressor
F4/80-positive
cells
compared
todisposition
the other groups
6A). The
myeloid-derived
cells
cells
compared
to
the
other
groups
(Figure
6A).
The
myeloid-derived
suppressor
cells
(MDSCs) expressed high levels of arginase-1 and were recruited to the tumor tissues [33].
(MDSCs)
expressed
high cells
levels
of arginase-1
were
recruited
the tumor
tissues
[33].
Most
arginase-1
positive
appeared
at theand
edges
of the
tumortotissues
to trigger
tumor
Most arginase-1
appeared
at the edges
of thetissues.
tumor tissues
to trigger
tumor
growth
and in thepositive
regionscells
between
the adipose
and tumor
A quantitative
analysis
growth
and indisposition
the regionsshowed
between
adipose difference
and tumorbetween
tissues. A
analysis
of
arginase-1
nothe
significant
thequantitative
groups (Figure
6B).
of arginase-1
disposition
showed no
difference
between
the groups
(Figure and
6B).
Most
CD4-positive
cells appeared
insignificant
the inflammatory
regions
between
the adipose
Most
CD4-positive
cells
appeared
in
the
inflammatory
regions
between
the
adipose
and
tumor tissues, with no significant differences between the groups in the CD4 disposition
(Figure 6C). Similar to the CD4 disposition, most of the CD8-positive cells also appeared
in the inflammatory regions between the fat and tumor tissues, showing no significant
difference between the groups in the CD8 disposition (Figure 6D).
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tumor tissues, with no significant differences between the groups in the CD4 disposition
(Figure 6C). Similar to the CD4 disposition, most of the CD8-positive cells also appeared
11 of 17
in the inflammatory regions between the fat and tumor tissues, showing no significant
difference between the groups in the CD8 disposition (Figure 6D).
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Figure 6. Immunohistochemical evaluation of immune cells in omental tumor tissues from a postmenopausal diet-induced
Figure 6. Immunohistochemical evaluation of immune cells in omental tumor tissues from a postmenopausal diet-induced
obese mouse model between CXCR2 WT and cKO mice. Histological features of (A) F4/80-, (B) arginase-1-, (C) CD4-, and
obese mouse model between CXCR2 WT and cKO mice. Histological features of (A) F4/80-, (B) arginase-1-, (C) CD4-, and
(D) CD8-positive cells in omental tumors from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. Quantitative analysis of
(D) CD8-positive cells in omental tumors from ND-WT, ND-cKO, HFD-WT, and HFD-cKO mice. Quantitative analysis
immune cell disposition was performed using ImageJ with brown color selection through color deconvolution of hemaof immune cell disposition was performed using ImageJ with brown color selection through color deconvolution of
toxylin
and DAB staining followed by intensity analysis. Quantitative analysis was obtained from 3–5 random fields of
hematoxylin
DAB staining
followed
by intensity
Quantitative
was obtained
from
3–5Tukey’s
randompairwise
fields
each
slide (10×).and
* indicates
a significant
difference
(p ≤ analysis.
0.05) between
groupsanalysis
as analyzed
by ANOVA
and
of
each
slide
(10
×
).
*
indicates
a
significant
difference
(p
≤
0.05)
between
groups
as
analyzed
by
ANOVA
and
Tukey’s
comparison tests.
pairwise comparison tests.

3.6. CXCR2 cKO Mice Showed a Higher Positive Relationship between Ascites and Tumor Parameters Compared to WT Mice
Because obese CXCR2 WT and cKO mice had greater tumor weights and ascites accumulation (Figure 2D,F), respectively, we evaluated the correlations between the tumor
weights, spleen weights, ascites accumulation, and survival between CXCR2 WT and cKO
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Because obese CXCR2 WT and cKO mice had greater tumor weights and ascites
accumulation (Figure 2D,F), respectively, we evaluated the correlations between the tumor weights, spleen weights, ascites accumulation, and survival between CXCR2
12 ofWT
17
and cKO mice. CXCR2 WT mice had a higher correlation between the tumor and spleen
weights (R2 = 0.47) than between the tumor weights and ascites (R2 = 0.06). On the contrary,
the CXCR2 cKO mice had a higher correlation between the tumor weights and ascites
0.50)
the tumor
and spleen
weights
(R2 = 0.01)
7A,B).7A,B).
Furthermore,
(R2 =than
0.50)between
than between
the tumor
and spleen
weights
(R2 =(Figure
0.01) (Figure
FurtherCXCR2
cKO
mice
had
a
higher
correlation
between
the
spleen
weights
and
(R2 =
more, CXCR2 cKO mice had a higher correlation between the spleen weightsascites
and ascites
2
0.70)
mice
= 0.06)
With7C).
regard
toregard
survival,
mice had
(R2 =than
0.70)WT
than
WT(Rmice
(R2(Figure
= 0.06)7C).
(Figure
With
to CXCR2
survival,WT
CXCR2
WT
2 = 0.22) than
2 = 0.06)
amice
higher
correlation
with
the
tumor
weights
(R
with
spleen
weights
(R
2
had a higher correlation with the tumor weights (R = 0.22) than with spleen weights
and
ascites
(R2 =ascites
0.001) (Figure
7D,F),
whereas
CXCR2
cKO CXCR2
mice had
similar
(R2 =
0.06) and
(R2 = 0.001)
(Figure
7D,F),
whereas
cKO
micecorrelations
had similar
2 = 0.14), spleen2weights (R2 = 0.18), and ascites
2 = 0.16), demon2
with
the
tumor
weights
(R
(R
correlations with the tumor weights (R = 0.14), spleen weights (R = 0.18),
and ascites
strating
survival
durations survival
which lasted
days which
(Figurelasted
7D,F).days
These
correlation
sug(R2 = 0.16),
demonstrating
durations
(Figure
7D,F). results
These corregested
that thesuggested
tumor and
ascites
burdens
be burdens
critical for
the
of CXCR2
WT
lation results
that
the tumor
and may
ascites
may
besurvival
critical for
the survival
and
cKO mice,
respectively.
of CXCR2
WT and
cKO mice, respectively.

Figure 7.
7. Correlations
Correlations in
in tumor
tumor parameters
parameters between
between CXCR2
CXCR2 WT
WT and
and cKO
cKO mice.
mice. (A)
(A) Correlation
Correlation of
of tumor
tumor and
and spleen
spleen
Figure
weights
from
CXCR2
WT
and
cKO
mice.
(B)
Correlation
of
tumor
weights
and
ascites
volumes
in
CXCR2
WT
and
cKO
weights from CXCR2 WT and cKO mice. (B) Correlation of tumor weights and ascites volumes in CXCR2 WT and cKO
mice. (C)
(C) Correlation
Correlation of
of spleen
spleen weights
weights and
and ascites
ascites volumes
volumes in
in CXCR2
CXCR2 WT
WT and
and cKO
cKO mice.
mice. (D)
(D)Correlation
Correlation of
of tumor
tumor weights
weights
mice.
and survival
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The crown-like structures in the adipose tissues indicated the adipose microenvironments of Mφ engulfing adipocytes, and their densities were usually higher in obese mice
than in lean mice [34]. Because HFD-fed mice increased the crown-like structures compared to ND-fed mice without any change between CXCR2 WT and cKO mice (Figure
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inducing diet conditions. On the contrary, CXCR2 WT mice seemed to have a higher tumor
burden rather than an ascites burden from OC under obese conditions.
The crown-like structures in the adipose tissues indicated the adipose microenvironments of Mϕ engulfing adipocytes, and their densities were usually higher in obese mice
than in lean mice [34]. Because HFD-fed mice increased the crown-like structures compared to ND-fed mice without any change between CXCR2 WT and cKO mice (Figure 1C),
adipocyte-specific CXCR2 cKO was unlikely to critically affect adipose tissue inflammation
under obese conditions. The average size of adipocytes was larger in obese mice than in
lean mice [35]. Consistent with the results, HFD-fed mice in our study showed an increased
adipocyte size compared to that in ND-fed mice, but no difference between the CXCR2 WT
and cKO mice (Figure 1D). Female CXCR2 KO mice had a thinner subcutaneous adipose
layer due to fewer and smaller adipocytes, which was not observed in male mice [25]. In
contrast to the systemic CXCR2 KO, the adipocyte-specific CXCR2 cKO may not critically
affect adipose morphology. On the other hand, the obese CXCR2 cKO mice had low levels
of CCL2/6 in the adipose tissues compared to obese WT mice (Figure 1E). The adipocytes
produced CCL2 which was correlated with body mass index (BMI), whereas weight loss
reduced CCL2 levels [36]. Surgery-induced weight loss also reduced urinary CCL2 levels [37]. Adipogenesis in mouse 3T3-L1 cells indicated CCL6 as a dominant chemokine
in mouse adipocytes [20]. These reports supported the HFD-induced CCL2/6 levels in
adipose tissues. Although CXCR2 cKO mice showed a normal adipose morphology, the
adipocyte-specific CXCR2 cKO may have affected the adipose microenvironment by disrupting the adipose CCL2/6 levels in response to HFD. The CXCR2 cKO mice showed a
similar weight trend with WT mice in response to ND and HFD (Figure 2A), supporting
the similar results of crown-like structures and adipocyte size in adipose tissues between
WT and cKO mice (Figure 1C,D).
As obesity increases the risk of OC progression and leads to enhanced tumor burden [38], HFD-induced obesity resulted in a shorter survival regardless of the CXCR2
in adipose tissues (Figure 2B). A shorter survival may be due to a greater tumor and
ascites burden in the HFD-fed CXCR2 WT and cKO, respectively (Figure 2D,F). These
results indicate that CXCR2-mediated signaling is involved in increased tumor burden in
the tumor microenvironment of OC by interacting with adipose tissues. Although obese
mice had a greater tumor burden compared to lean mice, the ascites accumulation was
unchanged [21]. Because the increased OC-induced ascites in HFD-fed CXCR2 cKO mice
(Figure 2F) was unexpected, we further analyzed the cellular and biochemical characteristics of ascites. Consistently, as ascites in ob/ob mice had higher levels of Mϕ than lean
mice [21], the HFD-fed CXCR2 WT mice demonstrated dominant floating tumor burdens
and tumor-attached Mo/Mϕ in OC-induced ascites. On the other hand, ascites in HFD-fed
cKO mice attenuated the floating tumor burdens and tumor-attached Mo/Mϕ compared
to HFD-fed WT mice (Figure 3A,D). Even ND-fed cKO mice reduced these parameters in
OC-induced ascites compared to ND-fed WT mice (Figure 3A,D). These results confirmed
that the adipocyte-specific CXCR2 cKO attenuated the tumor burden of OC in response to
HFD. CXCR2 KO mice also had a reduced tumor volume after the injection with breast
cancer cells [39], supporting the attenuated tumor burdens in adipocyte-specific CXCR2
cKO mice. Interestingly, HFD-fed CXCR2 cKO mice showed increased cytoplasmic lipid
droplets of cell clumps in the OC-induced ascites (Figure 3E). The relationship between the
increased vacuole clumps and ascites volume was unclear at this point, requiring further
study. The increased vacuole clumps may be associated with lower levels of triglycerides
and free fatty acids as observed more in the OC-induced ascites of cKO mice than in
WT mice (Figure 4A,B), forming further vacuole clumps to reduce the amount of fat in
the ascites. On the other hand, the ascites of ND-fed cKO mice showed higher levels of
triglycerides and free fatty acids compared to that of ND-fed WT mice (Figure 4A,B). These
increased levels may be in part associated with decreased Mϕ in ascites of ND-fed cKO
mice (Figure 4D) because Mϕ could accumulate lipids via phagocytosis. VEGF was a
permeability factor for endothelial cells to play a role in angiogenesis [40]. Because VEGF
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levels in ascites was similar between WT and cKO mice (Figure 4G), VEGF was unlikely
to be a factor for the OC-induced ascites in CXCR2 cKO mice. CXCR2-deficient mice had
reduced the blood–brain barrier permeability in viral encephalitis [41] but the permeability
was not affected by closed head injury [42], indicating a disease-specific response.
Among chemokine signatures in OC-induced ascites, CCL2 had a significantly higher
expression in HFD-fed WT mice (Figure 4C,D), indicating that CCL2 may be an important
player in the peritoneal microenvironment of OC under obese conditions. CCL2 is known
to be markedly increased in obesity, with roles in Mo recruitment [43]. Our previous results
also showed high levels of CCL2 in ob/ob mice with leptin deficiency [21]. On the other
hand, HFD-fed CXCR2 cKO mice had lower levels of secreted TNFα compared to obese
WT mice (Figure 4H). TNFα was shown to be significantly upregulated in ovarian tumor
tissues, leading to NF-κB activation [44]. Because CCL2, CXCL1, CXCL2, CXCL5, and
CXCL10 were upregulated by NF-κB signaling [14,45,46], TNFα-induced NF-κB activation
may have contributed to the increased tendencies of these chemokines in HFD-fed WT mice
(Figure 4D). Glioblastoma cell-secreted CXCL8 induced brain endothelial cell permeability
via CXCR2 [47]. As the mice lacked IL8/CXCL8, the murine homologues for human
CXCL8 were considered to be CXCL1–2 and CXCL5, as CXCR2 ligands [48]. Because
CXCL1–2 and CXCL5 levels showed a decreased tendency in ascites of HFD-fed CXCR2
cKO mice, compared to the WT mice (Figure 4D), these chemokines were unlikely to
contribute to OC-induced ascites in HFD-fed CXCR2 cKO mice. CCL2 secreted from
cancer-associated mesothelial cells could promote the malignant potential of OC, playing a
crucial role in the tumor microenvironment of OC [49]. However, the increased ovarian
tumoral expression of CCL2 was associated with an improved response to chemotherapy
and survival outcomes [50]. Despite the controversial effects of CCL2 in OC, the CCL2CCR2 axis was recognized as a critical player in recruiting tumor-associated Mϕ and
facilitating the progression of cancer [51], indicating further promoting effects due to
obesity. Although ID8 OC cells constitutively expressed CCL2 [46], adipocyte-conditioned
media had no effects on CCL2 but instead induced CXCL1, CXCL2, and CXCL10 in ID8
cells [21]. Therefore, the higher levels of CCL2 in the ascites of obese WT mice may be
derived not from tumoral tissues but from obesity-related, extra-tumoral tissues including
adipocytes, as observed in adipose tissues (Figure 1E). Although showing a similar weight
gain (Figure 2A) and similar distribution pattern of body fat (Figure 2C) with WT mice,
obese CXCR2 cKO mice showed lower levels of triglyceride, FFA, CCL2, and Mϕ in ascites
compared to obese WT mice (Figure 4). These results indicated that CXCR2 cKO obesity
critically responded to a pathological state rather than a physiological state. As a future
research direction, the quantitative analysis of physiological aspects, such as the food
intake pattern, fat distribution, and lipid metabolism, may give an important insight to
clarify the underlying mechanisms affecting the roles of CXCR2 in obesity.
The tumor tissues in HFD-fed CXCR2 cKO mice had lower inflammatory areas and
PCNA and F4/80 expressions, compared to those in HFD-fed WT mice (Figures 5 and 6A),
indicating a reduced tumor burden. These facts indicated that CXCR2-mediated signaling
was involved in tumor burden, showing immune cell infiltration in the tumor microenvironment. Consistently, systemic CXCR2 KO mice decreased PCNA and F4/80 tumor
associated Mϕ in mammary tumors [39]. CXCR2 KO mice also suppressed acute and
chronic pancreatic inflammation [52]. While CXCR2 KO mice decreased MDSCs in breast
tumors [39], adipose-specific CXCR2 cKO mice had no change in omental tumor tissues of
OC (Figure 6B). Particularly, the regions between the fat and tumor tissues were the main
target areas for immune cell infiltration, indicating the immune cell-mediated interaction
between the adipocytes and cancer cells followed by the higher potentiation of PCNA and
F4/80-positive cells under obese conditions. In addition, based on the correlation results
(Figure 7), CXCR2 WT and cKO mice could favorably induce tumor and ascites burdens,
respectively, playing a critical role in OC survival.
We summarized how adipocyte-specific CXCR2 cKO affected the peritoneal dissemination of OC under HFD-induced obese models based on our current results (Figure 8).
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As CCL2 is known to function in Mo/Mϕ recruitment [43], the high levels of CCL2 in the
adipose tissues and OC-induced ascites of HFD-fed WT mice could contribute to increased
Mo/Mϕ in the ascites and omental tumors. Overall, obese CXCR2 WT mice were likely
prone to drive OC progression through tumor growth, while obese cKO mice favored
ascites accumulation, which required further study to identify the molecular mechanisms.
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